Solicitor General Elizabeth Prelogar
Should SCOTUS hear Amgen's Repatha case? Solicitor general says no
Back in April, Amgen said it was encouraged by the solicitor general’s anticipated review of its Supreme Court petition to rehear a Repatha patent case …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
